U.S. Food and Drug Administration said on Wednesday it approved Astellas Pharma ...
FILE PHOTO: Astellas Pharma's logo is pictured at its headquarters in Tokyo, Japan, December 3, 2019. REUTERS/Kim Kyung-Hoon
The drug will treat patients with advanced bladder cancer whose disease has progressed even after treatment with immunotherapy and chemotherapy.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Special Report: FDA targets e-cigs that hook teens but don't help smokers quitE-cigarette makers face an existential threat. By May, they must submit applicat...
Consulte Mais informação »
FDA approves omega-3 fish-oil medication Vascepa to reduce risk of death in people with high cholesterolThe Federal Drug Administration announced late last week that a fish-oil-derived medication, Vascepa, had been approved to prevent heart attacks, strokes and death in people who are at high cardiovascular risk. 'The FDA recognizes there is a need for additional medical treatments for cardiovascular
Consulte Mais informação »
FDA approves omega-3 fish-oil medication Vascepa to reduce risk of death in people with high cholesterolFDA approves Vascepa, a fish-oil-derived medication that could help prevent heart attacks, strokes and death in people who are at high cardiovascular risk.
Consulte Mais informação »
Josh Gordon of the Seattle Seahawks has been suspended againFor the fifth time since 2013, wide receiver Josh Gordon of the Seattle Seahawks has been suspended for some form of substance abuse
Consulte Mais informação »
Scientists make 'exciting' advancement in certain breast cancer drugsTwo new drug treatments for HER2-positive breast cancer were tested in separate studies. One study involves the drug Tucatinib, and the other involves an antibody-drug called trastuzumab deruxtecan.
Consulte Mais informação »